Since its inception, Q-LINE BIOTECH has grown rapidly both through organic growth as well as through strategic acquisitions. Every year had been a particularly phenomenal period for Q-LINE BIOTECH as significant value has been added to the business in this way. I would like to congratulate my Q-LINE BIOTECH Team for their contribution to our sales growth and leadership abilities.

Demand for efficient and state-of-the-art healthcare services is expected to continue its upward trajectory and become increasingly sophisticated, driven by high population growth rates, plateauing government healthcare capacity and the widened scope of health insurance in the Country.

Q-LINE BIOTECH has evolved being one of the fastest growing healthcare groups in the country and is set to expand both in scale and market reach through its operating brands in addition to exploring new hospital projects. Q-LINE BIOTECH will also look at potential expansion into the wider region of the Country, with the aim of maintaining a market leadership position for all of its brands.